Table 2.
Correlation of B3GALT5-AS1 expression with clinicopathologic characteristics in HCC patients.
| Characteristic | Case | B3GALT5-AS1 expression | P value | |
|---|---|---|---|---|
| Low | High | |||
| All case | 56 | 28 | 28 | |
| Age (years) | 0.584 | |||
| <60 | 22 | 10 | 12 | |
| ≥60 | 34 | 18 | 16 | |
| Gender | 0.788 | |||
| Female | 25 | 12 | 13 | |
| Male | 31 | 16 | 15 | |
| Tumor size (cm) | 0.022∗ | |||
| <5 cm | 38 | 23 | 15 | |
| ≥5 cm | 18 | 5 | 13 | |
| Liver cirrhosis | 0.313 | |||
| No | 11 | 4 | 7 | |
| Yes | 45 | 24 | 21 | |
| HBsAg status | 0.515 | |||
| Negative | 12 | 5 | 7 | |
| Positive | 44 | 23 | 21 | |
| AFP (ng/ml) | 0.108 | |||
| ≤20 | 26 | 16 | 10 | |
| >20 | 30 | 12 | 18 | |
| Tumor multiplicity | 0.383 | |||
| Single | 39 | 21 | 18 | |
| Multiple | 17 | 7 | 10 | |
| Edmondson grade | 0.42 | |||
| I–II | 31 | 17 | 14 | |
| III–IV | 25 | 11 | 14 | |
| TNM stage | 0.003∗ | |||
| I–II | 33 | 22 | 11 | |
| III–IV | 23 | 6 | 17 | |